Key result
COVID-19 mRNA vaccine linked to early cardiac tamponade requiring pericardiocentesis in an 18-year-old man.
Why the study?
The association between acute pericarditis and the immunogenic response to COVID-19 vaccines is still being fully characterized.
Population
One previously healthy 18-year-old man
Design
Case report
Authors
Loading...
Case of post-vaccination pericarditis warrants vigilance in young adults; hypothesis-generating and leaves open questions on incidence and causality.
Case Report (n=1)
Highlights acute pericarditis with cardiac tamponade as a rare but potentially serious adverse event associated with COVID-19 mRNA vaccination.
Hryniewicki et al. (2021) conducted a case report in Cardiac Tamponade (n=1). COVID-19 mRNA-based vaccine was evaluated on Cardiac tamponade requiring pericardiocentesis. A previously healthy 18-year-old man developed a large pericardial effusion with early tamponade physiology requiring pericardiocentesis 3 weeks after his first COVID-19 mRNA vaccine dose.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: